Six RCM Tips from the ADLM 2026 Meeting
Watch for panel unbundling, Medicare spending shifts, and frequency-based denials
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Watch for panel unbundling, Medicare spending shifts, and frequency-based denials
These core steps are fundamental for protecting laboratory workers from airborne contamination
The proposal seeks to move any future LDT authority away from the FDA
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
FDA-CMS collaboration aims to accelerate Medicare coverage determinations of certain medical devices
Expert Ashley Zarling details nuances for clinical lab directors and compliance teams
A closer look at what changed in OSHA’s operations that could affect medical laboratories
In both cases, the diagnostic tests report results back within 15 minutes
But anti-regulatory stance taken by Trump administration could serve as a potential obstacle in the effort